These results clearly indicate a mechanistic link between dysfunctional M6P/IGF2R expression and HCC pathogenesis, in agreement with the tumor-suppressive activities of the receptor in other forms of cancer [22,37]. The gene discussed is IGF2R; the disease is cancer.